These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21228789)

  • 1. More than a REASON to use arterial stiffness as risk marker and therapeutic target in hypertension.
    Angeli F; Reboldi G; Verdecchia P
    Hypertens Res; 2011 Apr; 34(4):445-7. PubMed ID: 21228789
    [No Abstract]   [Full Text] [Related]  

  • 2. Responses of the ambulatory arterial stiffness index and other measures of arterial function to antihypertensive drugs.
    Jin Y; Thijs L; Richart T; Li Y; Dolan E; Wang JG; Protogerou A; O'Brien E; Staessen JA; Safar ME
    Hypertens Res; 2011 Apr; 34(4):489-95. PubMed ID: 21228786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol.
    Asmar RG; London GM; O'Rourke ME; Safar ME;
    Hypertension; 2001 Oct; 38(4):922-6. PubMed ID: 11641310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.
    Protogerou A; Blacher J; Stergiou GS; Achimastos A; Safar ME
    J Am Coll Cardiol; 2009 Feb; 53(5):445-51. PubMed ID: 19179203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
    Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
    Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of arterial properties with a perindopril-indapamide very-low-dose combination.
    Asmar RG; London GM; O'Rourke ME; Mallion JM; Romero R; Rahn KH; Trimarco B; Fitzgerald D; Hedner T; Duprez D; De Leeuw PW; Sever P; Battegay E; Hitzenberger G; de Luca N; Polónia P; Bénétos A; Chastang C; Ollivier JP; Safar ME;
    J Hypertens Suppl; 2001 Nov; 19(4):S15-20. PubMed ID: 11848258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combination of low-dose perindopril/indapamide versus atenolol in the hypertensive patient. Effects on systolic pressure and arterial hemodynamics. REASON Study].
    Pannier B; Guérin A; London G; Asmar R; Safar M;
    Arch Mal Coeur Vaiss; 2002 Sep; 95 Spec No 6():11-6. PubMed ID: 12407781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perindopril/indapamide combination in the first-line treatment of hypertension and end-organ protection.
    Gosse P
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):319-33. PubMed ID: 16716093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
    Williams B; Lacy PS; Thom SM; Cruickshank K; Stanton A; Collier D; Hughes AD; Thurston H; O'Rourke M; ; ;
    Circulation; 2006 Mar; 113(9):1213-25. PubMed ID: 16476843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of perindopril and its combination with indapamide on risk stratification in patients with hypertension].
    Ol'binskaia LI; Zheleznykh EA
    Ter Arkh; 2001; 73(9):22-4. PubMed ID: 11642074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arterial stiffness, wave reflections and myocardial protection: the REASON project].
    London GM
    Drugs; 2003; 63 Spec No 1():9-17. PubMed ID: 12708879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very-low-dose combination of perindopril and indapamide as a novel strategy in first-line management of hypertension.
    de Leeuw PW; ;
    J Hypertens Suppl; 2001 Sep; 19(3):S41-5. PubMed ID: 11713850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive therapy and de-stiffening of the arteries.
    Safar ME; Jankowski P
    Expert Opin Pharmacother; 2010 Nov; 11(16):2625-34. PubMed ID: 20977399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulse pressure reduction and cardiovascular protection.
    Laurent S; Tropeano AI; Boutouyrie P
    J Hypertens Suppl; 2006 May; 24(3):S13-8. PubMed ID: 16723861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of the perindopril/indapamide combination therapy for hypertension: the PRIMUS study.
    Holzgreve H; Risler T; Trenkwalder P
    Curr Med Res Opin; 2006 Sep; 22(9):1849-58. PubMed ID: 16968588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Need of antihypertensive therapy in patients aged 80 years or more].
    Waeber B; Burnier M; Lüscher T; Hess O
    Praxis (Bern 1994); 2008 May; 97(10):563-6. PubMed ID: 18595372
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of arterial stiffness reduction on urinary albumin excretion during antihypertensive treatment: the Japan morning Surge-1 study.
    Matsui Y; Eguchi K; Shibasaki S; Ishikawa J; Hoshide S; Shimada K; Kario K;
    J Hypertens; 2010 Aug; 28(8):1752-60. PubMed ID: 20485195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shear stress as target to reduce atherosclerosis progression in hypertensive patients.
    Marfella R; Bologna C; Quaranta E; Paolisso G
    Am J Hypertens; 2008 Jul; 21(7):729. PubMed ID: 18584017
    [No Abstract]   [Full Text] [Related]  

  • 19. Significance of central aortic stiffness in cardiovascular disease.
    Arora R; Khandpur R
    Am J Ther; 2009; 16(6):e60-7. PubMed ID: 19092645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of the angiotensin-converting enzyme inhibitor perindopril and the diuretic indapamide activate postnatal vasculogenesis in spontaneously hypertensive rats.
    You D; Cochain C; Loinard C; Vilar J; Mees B; Duriez M; Lévy BI; Silvestre JS
    J Pharmacol Exp Ther; 2008 Jun; 325(3):766-73. PubMed ID: 18309090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.